News
The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...
The abstract of the RENAL Replacement Therapy study concludes that in critically ill patients with acute kidney injury, treatment with higher-intensity continuous renal replacement therapy did not ...
1mon
GlobalData on MSNNicklaus Children’s Hospital acquires Carpediem system for newborn dialysisCarpediem offers a miniaturised platform and enhances the precision of neonatal continuous renal replacement therapy (CRRT) ...
We offer robust inpatient and outpatient rotations, focused on all forms of renal replacement therapy (hemodialysis, continuous renal replacement therapies, peritoneal dialysis and home therapies), ...
CRRT = continuous renal replacement therapy; ICU = intensive care unit; IQR = interquartile range; LOS = length of stay; SOFA = sequential organ function assessment. a Using conditional logistic ...
Hosted on MSN2mon
Rodman & Renshaw sets Talphera stock Buy rating, $4 targetThe company has not yet announced a specific date for releasing data from the ongoing NEPHRO CRRT (Nafamostat Efficacy in Phase 3 Registrational Continuous Renal Replacement Therapy) study.
To provide medical professionals (RN, MD, Pharmacist) with the knowledge and understanding for decision making for the effective utilization of Continuous Renal Replacement Therapy (CRRT) and to allow ...
The specialized staff offers peritoneal dialysis, hemodialysis, continuous renal replacement therapies ... Multi-center studies determine the optimal immunosuppression therapy to maximize long-term ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results